BATS BZX Real-Time Price
 +0.395 / +0.63%
Today’s Change
Today|||52-Week Range
Will Biogen (BIIB) Surpass Q4 Earnings Expectations? - Analyst Blog
12:32pm / Zacks.com
Will Intuitive Surgical (ISRG) Disappoint Earnings in Q4? - Analyst Blog
Jan 20 / Zacks.com
Will Vertex (VRTX) Surprise with a Lower Loss in Q4? - Analyst Blog
11:59am / Zacks.com
Will Quality Systems (QSII) Surprise Earnings this Quarter? - Analyst Blog
Jan 20 / Zacks.com
Can CR Bard (BCR) Keep the Earnings Streak Alive in Q4? - Analyst Blog
11:07am / Zacks.com
Can AbbVie Inc. Overcome Humirabs Looming Patent Expiration?
Jan 20 / MotleyFool.com
Pfizer Beats on Q4 Earnings, Guides Below Expectations - Analyst Blog
11:07am / Zacks.com
AbbVie Gains EU Approval for Hepatitis C Virus Treatment - Analyst Blog
Jan 19 / Zacks.com
Pfizer, Inc. Should Forget AstraZeneca and Buy This Company Instead
7:56am / MotleyFool.com
Roche to Acquire French Biotechnology Company Trophos - Analyst Blog
Jan 19 / Zacks.com
Medtronic: the tax inversion that got away
6:36am / FT.com
Celgene Up as Otezla Gains EU Approval for Two Indications - Analyst Blog
Jan 19 / Zacks.com
These 3 Dividend Stocks Could Crush the Market in 2015
Jan 24 / MotleyFool.com
Is 1 Drug Really Outselling Legalized Marijuana?
Jan 19 / MotleyFool.com
Will Accuray (ARAY) Disappoint Earnings Estimates in Q2? - Analyst Blog
Jan 23 / Zacks.com
Will Pharmaceutical Segment Drive J&J Q4 Earnings Again? - Analyst Blog
Jan 19 / Zacks.com
Sanofi's Cerdelga Cleared in the EU for Gaucher Disease - Analyst Blog
Jan 23 / Zacks.com
Will Logitech (LOGI) Keep the Earnings Streak Alive in Q3? - Analyst Blog
Jan 19 / Zacks.com
Will Oncology Products Drive Bristol-Myers (BMY) Earnings? - Analyst Blog
Jan 23 / Zacks.com
Gilead and AbbVie take hepatitis C battle to Europe
Jan 18 / FT.com
Will Stryker (SYK) Disappoint this Earnings Season? - Analyst Blog
Jan 23 / Zacks.com
AbbVie Inc.'s Insights at the JP Morgan Healthcare Conference
Jan 15 / MotleyFool.com
Will Pfizer (PFE) Beat Q4 Earnings Despite Generics? - Analyst Blog
Jan 23 / Zacks.com
Gilead Sciences, Inc. Is No Longer Just an HIV Company
Jan 14 / MotleyFool.com
11 Dividend Stocks Buffett, Soros and Other Billionaires Love
Jan 22 / TheStreet.com
3 Stocks to Buy When the Market Crashes
Jan 14 / MotleyFool.com
Why Johnson & Johnson's Stock Could Crater in 2015
Jan 21 / MotleyFool.com
How Much Could AbbVie Inc. Make Selling Its Hepatitis C Drug This Year?
Jan 14 / MotleyFool.com
Biotech Stock Roundup: EU Approvals for AbbVie & Celgene Drugs, CytRx Partial Clinica...
Jan 21 / Zacks.com
Perrigo/Ferrara Candy Ink Supply Deal for Gummy Products - Analyst Blog
Jan 13 / Zacks.com
Novartis' Cosentyx Approved in Europe for Plaque Psoriasis - Analyst Blog
Jan 20 / Zacks.com
Did Gilead Sciences' Sales Soar in Q4?
Jan 13 / MotleyFool.com
Sanofi and Boehringer Ingelheim Ink Strategic Deal - Analyst Blog
Jan 20 / Zacks.com
Labour price pledge hits UK energy stocks
Jan 12 / FT.com
Novo Nordisk's Xultophy to Launch First in Switzerland - Analyst Blog
Jan 20 / Zacks.com
Pharma takeover battles boost FTSE 100 performance
Jan 07 / FT.com
Johnson & Johnson Overcomes Threats from Competitors, Delivers Solid Quarterly Result...
Jan 20 / MotleyFool.com
Gilead hepatitis-C drug wins CVS/Caremark backing
Jan 05 / FT.com
J&J Beats on Q4 Earnings, Revenues Hit by Currency - Analyst Blog
Jan 20 / Zacks.com

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.